Herantis Pharma Oyj Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2024: USD 1.54 M

Herantis Pharma Oyj Selling, General, and Administrative Expenses (SG&A) is USD 1.54 M for the year ending December 31, 2024, a 80,359.74% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • Herantis Pharma Oyj Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2023 was USD 1.92 K, a -99.93% change year over year.
  • Herantis Pharma Oyj Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2022 was USD 2.83 M, a -12.64% change year over year.
  • Herantis Pharma Oyj Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2021 was USD 3.24 M, a 30.51% change year over year.
  • Herantis Pharma Oyj Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2020 was USD 2.49 M, a -5.09% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue